拓扑异构酶II靶向抗肿瘤药物的作用机制。 - Suppr

Suppr

超能文献

Mechanism of action of topoisomerase II-targeted antineoplastic drugs.

作者信息

Osheroff N, Corbett A H, Robinson M J

机构信息

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37332-0146, USA.

出版信息

Adv Pharmacol. 1994;29B:105-26. doi: 10.1016/s1054-3589(08)61134-5.

DOI:10.1016/s1054-3589(08)61134-5

PMID:8996604

Abstract

摘要

相似文献

Mechanism of action of topoisomerase II-targeted antineoplastic drugs.拓扑异构酶II靶向抗肿瘤药物的作用机制。

Adv Pharmacol. 1994;29B:105-26. doi: 10.1016/s1054-3589(08)61134-5.

Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.拓扑异构酶II靶向药物对酶介导的DNA切割和ATP水解的影响：拓扑异构酶II上不同药物相互作用结构域的证据。

Biochemistry. 1993 Apr 13;32(14):3638-43. doi: 10.1021/bi00065a016.

Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.对接受拓扑异构酶导向药物治疗的患者白血病细胞中拓扑异构酶-DNA复合物进行定量分析。

Cancer Chemother Pharmacol. 1994;34(3):249-56. doi: 10.1007/BF00685085.

Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells.拓扑异构酶II干扰药物在阿霉素敏感和耐药大鼠胶质母细胞瘤细胞中诱导的DNA损伤与生长抑制之间的关系。

Anticancer Res. 1994 Jan-Feb;14(1A):99-103.

Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.雌激素诱导拓扑异构酶II相互作用抗肿瘤药物处理的人乳腺癌细胞中DNA损伤和细胞毒性的增强。

Cancer Res. 1988 Jan 15;48(2):297-303.

Mechanisms of resistance to drugs that inhibit DNA topoisomerases.对抑制DNA拓扑异构酶药物的耐药机制。

Semin Cancer Biol. 1991 Aug;2(4):235-44.

A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine.一种对非循环细胞具有活性的安吖啶氨基甲酸酯类似物，可刺激拓扑异构酶II在与安吖啶不同的DNA位点进行切割。

Eur J Cancer. 1997 Feb;33(2):272-9. doi: 10.1016/s0959-8049(96)00410-8.

Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme.利用不同药物类别之间的机制差异来确定拓扑异构酶II上的功能性药物相互作用域。有证据表明，几种不同的DNA切割增强剂在该酶上具有共同的作用位点。

J Biol Chem. 1993 Jul 5;268(19):14394-8.

Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.喹诺酮类药物与其他增强DNA裂解的抗肿瘤药物在拓扑异构酶II上具有共同的相互作用域。

Biochemistry. 1997 Mar 11;36(10):2919-24. doi: 10.1021/bi962488f.

Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An Approach.非 synonymous 多态性改变人 DNA 拓扑异构酶 II - alpha 与安吖啶和米托蒽醌相互作用的研究：一种方法。

Curr Cancer Drug Targets. 2017;17(7):657-668. doi: 10.2174/1568009617666161109142629.

引用本文的文献

Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP).抑制金属蛋白酶ADAM19作为一种新型的衰老形态调节策略，通过调节衰老相关分泌表型（SASP）来改善肠道通透性和衰老标志物。

Aging (Albany NY). 2025 Mar 20;17(3):757-777. doi: 10.18632/aging.206224.

A network-based trans-omics approach for predicting synergistic drug combinations.一种基于网络的跨组学方法用于预测协同药物组合。

Commun Med (Lond). 2024 Jul 29;4(1):154. doi: 10.1038/s43856-024-00571-2.

Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.生物类黄酮促进MLL - AF9断点簇区域之间的稳定易位，与正常染色体背景无关：用于筛选环境风险的模型系统。

Environ Mol Mutagen. 2019 Mar;60(2):154-167. doi: 10.1002/em.22245. Epub 2018 Nov 2.

DNA Topoisomerase II-alpha as a marker of cell proliferation in endocrine and other neoplasms.DNA拓扑异构酶II-α作为内分泌及其他肿瘤中细胞增殖的标志物。

Endocr Pathol. 1999 Jun;10(2):97-102. doi: 10.1007/BF02739821.

Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes.用于靶向和杀死循环肿瘤细胞同时排斥白细胞的纳米结构表面。

J Nanomater. 2012;2012. doi: 10.1155/2012/831263.

Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.流体剪切应力通过三聚体死亡受体使癌细胞对受体介导的凋亡敏感。

New J Phys. 2013 Jan 18;15:015008. doi: 10.1088/1367-2630/15/1/015008.

Double-strand break repair by interchromosomal recombination: an in vivo repair mechanism utilized by multiple somatic tissues in mammals.通过染色体间重组进行双链断裂修复：一种哺乳动物多种体细胞组织利用的体内修复机制。

PLoS One. 2013 Dec 13;8(12):e84379. doi: 10.1371/journal.pone.0084379. eCollection 2013.

Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells.癌症中的物理生物学。3. 细胞糖萼在循环肿瘤细胞血管运输中的作用。

Am J Physiol Cell Physiol. 2014 Jan 15;306(2):C89-97. doi: 10.1152/ajpcell.00285.2013. Epub 2013 Oct 16.

Computational and experimental models of cancer cell response to fluid shear stress.癌症细胞对流体切应力反应的计算和实验模型。

Front Oncol. 2013 Mar 5;3:44. doi: 10.3389/fonc.2013.00044. eCollection 2013.

Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.米托蒽醌抑制星形胶质细胞激活：与多发性硬化症的相关性。

Brain Res. 2012 Sep 14;1473:236-41. doi: 10.1016/j.brainres.2012.07.054. Epub 2012 Aug 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验